Today we end the season of the #VASCERN#SpringMeetings with the #HHT Working Group in Paris.
An opportunity for the group to share their updates about #genetics, #european patient regisitries, clinical cases and much more. Thank you to all to make it happen!
🤗🤗🤗 I'm glad and happy to announce that our grant proposal "Hypoxia-inducible factor in hereditary hemorrhagic telangiectasia" has been approved for funding by the @dfg_public 🥳🥳🥳 #HHT#HIF@freyadroege@unidue@MedEssen
AG-Jablonska style b-day present!!! 🥳The best b-day gift to the best PI (@JagaJablonska); a “Neutrophils Adventskalender“ 🫶🏼 We wish the happiest birthday to the captain of our ship. Thank you for your endless brainpower and unconditional support. 🙌 We love you sooo much! 🥹❤️
Inspiring milestones! 🌟 Our rare Disease Working Group chairs shared updates on year-long projects, showcasing remarkable achievements and dedication to advancing research and #PatientCare#VASCERNDays2023#rarediseases#research
🥳Happy to share our latest publication on #HIF and #HHT
Hypoxia-Inducible Factor–Prolyl Hydroxylase Inhibitor Improves Leukocyte Energy Metabolism in Hereditary Hemorrhagic Telangiectasia https://t.co/eiUtMh90xG #mdpilife via @Life_MDPI@freyadroege
#Shareyourcolours 🫶 Heute ist #RareDiseaseDay , der internationale Tag der seltenen Erkrankungen. Seit 10 Jahren versorgt das EZSE Betroffene in strukturierten interdisziplinären Versorgungspfaden. Wir am EZSE @UniklinikEssen bekennen Farbe. Wer noch ? #SeltenSindViele @ACHSEeV
Learn about Hereditary Haemorrhagic Telangiectasia and the lungs in this insightful #webinar with clinicians & #patient representatives from the #HHT-WG.
It's packed with valuable info and an interactive Q&A session. Don't miss out!
Watch it here 👉 https://t.co/hzhHYtlSqO
📢 LIVE FROM VASCERN DAYS 2022!!!
VASCERN Days has kicked off! The coordination team is presenting all the achievements and new updates of VASCERN over the past year.
#VASCERNDays2022#ERNeu#rarediseases#seminar#conference